花都影视

Annual report [Section 13 and 15(d), not S-K Item 405]

Assets and Liabilities Measured at Fair Value

v3.25.4
Assets and Liabilities Measured at Fair Value
12 Months Ended
Dec. 31, 2025
Assets and Liabilities Measured at Fair Value
Assets and Liabilities Measured at Fair Value

(6)听听Assets and Liabilities Measured at Fair Value

For assets and liabilities required to be reported at fair value, GAAP provides a hierarchy that prioritizes inputs to valuation techniques used to measure fair value into three broad levels. Level听1 inputs are quoted market prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level听2

inputs are inputs, other than quoted market prices included within Level听1, that are observable for the asset or liability, either directly or indirectly. Level听3 inputs are unobservable inputs for the asset or liability. The Company does not have any recurring assets or liabilities measured at fair value that would be considered Level听3.

花都影视鈥檚 assets and liabilities measured at fair value are as follows:

December听31,听2025

December听31,听2024

听听鈥嬏嬏

听听鈥嬏嬏

Quoted听prices

听听鈥嬏嬏

Significant听other

听听鈥嬏嬏

听听鈥嬏嬏

Quoted听prices

听听鈥嬏嬏

Significant听other

in听active听markets

observable

in听active听markets

observable

for听identical听assets

inputs

for听identical听assets

inputs

Total

(Level听1)

(Level听2)

Total

(Level听1)

(Level听2)

amounts听in听millions

Cash equivalents

听听鈥嬏嬏

$

783

听听鈥嬏嬏

783

听听鈥嬏嬏

听听鈥嬏嬏

2,142

听听鈥嬏嬏

2,142

听听鈥嬏嬏

听听鈥

Financial instrument assets

$

122

听听鈥嬏嬏

109

听听鈥嬏嬏

13

167

听听鈥嬏嬏

84

听听鈥嬏嬏

83

Debt

$

597

听听鈥嬏嬏

听听鈥嬏嬏

597

588

听听鈥嬏嬏

听听鈥嬏嬏

588

Financial instrument liabilities

$

138

138

The majority of 花都影视鈥檚 Level听2 financial instruments are debt related instruments and derivative instruments, which include foreign currency forward contracts and interest rate swaps. These assets and liabilities are not always traded publicly or not considered to be traded on 鈥渁ctive markets,鈥 as defined in GAAP. The fair values for such instruments are derived from a typical model using observable market data as the significant inputs or a trading price of a similar asset or liability is utilized. Accordingly, those financial instruments and debt or debt related instruments are reported in the foregoing table as Level听2 fair value. As of December 31, 2025, financial instrument assets included in the table above are included in the other assets line item in the consolidated balance sheet. As of December 31, 2024, $27 million and $140 million of financial instrument assets included in the table above are included in the other current assets and other assets line items, respectively, in the consolidated balance sheet. As of December 31, 2024, financial instrument liabilities included in the table above are comprised of foreign currency forward contracts.

Realized and Unrealized Gains (Losses) on Financial Instruments, net

Realized and unrealized gains (losses) on financial instruments, net are comprised of changes in the fair value of the following (amounts in millions):

Years听ended听December听31,

听听鈥嬏嬏

2025

听听鈥嬏嬏

2024

听听鈥嬏嬏

2023

Debt measured at fair value (a)

$

(6)

(95)

(13)

Foreign currency forward contracts

335

(138)

Interest rate swaps

(41)

103

28

Debt and equity securities

(12)

(5)

27

Other

12

(4)

2

$

288

(139)

44

(a) The Company elected to account for its convertible notes (as described in note 8) using the fair value option. Changes in the fair value of the convertible notes recognized in the consolidated statements of operations are primarily due to market factors primarily driven by changes in the fair value of the underlying shares into which the debt is exchangeable. The Company isolates the portion of the unrealized gain (loss) attributable to changes in the instrument specific credit risk and recognizes such amount in other comprehensive earnings (loss). The change in the fair value
of the convertible notes attributable to changes in the instrument specific credit risk was a loss of $4 million, loss of $15 million and loss of $12 million for the years ended December 31, 2025, 2024 and 2023, respectively. The cumulative change since issuance was a gain of $65 million as of December 31, 2025, net of the recognition of previously unrecognized gains and losses.